Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) ; volume:64 ; number:4 ; day:24 ; month:1 ; year:2009 ; pages:769-775 ; date:9.2009
Cancer chemotherapy and pharmacology ; 64, Heft 4 (24.1.2009), 769-775, 9.2009
- Creator
-
Brandes, Alba A.
Tosoni, A.
Franceschi, E.
Blatt, V.
Santoro, A.
Faedi, M.
Amistà, P.
Gardiman, M.
Labianca, R.
Bianchini, C.
Ermani, M.
Reni, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-009-0926-8
- URN
-
urn:nbn:de:101:1-2021090120515230486392
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Brandes, Alba A.
- Tosoni, A.
- Franceschi, E.
- Blatt, V.
- Santoro, A.
- Faedi, M.
- Amistà, P.
- Gardiman, M.
- Labianca, R.
- Bianchini, C.
- Ermani, M.
- Reni, M.
- SpringerLink (Online service)
Other Objects (12)
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
Il Gruppo Familiare
Skulptur "Gruppo Mitriaco"
Gruppo Della Galita
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
Laokoongruppe - Gruppo del Laoconte
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Vereinsregisterakte: Gruppo Culturale Italo-Tedesco
Sulle Generatrici del Gruppo Simmetrico.
Due, [...]. Edizione internazionale / Gruppo Meta
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
Il Gruppo Familiare
Skulptur "Gruppo Mitriaco"
Gruppo Della Galita
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
Laokoongruppe - Gruppo del Laoconte
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Vereinsregisterakte: Gruppo Culturale Italo-Tedesco
Sulle Generatrici del Gruppo Simmetrico.
Due, [...]. Edizione internazionale / Gruppo Meta
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol
Il Gruppo Familiare
Skulptur "Gruppo Mitriaco"
Gruppo Della Galita
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review
Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
Laokoongruppe - Gruppo del Laoconte
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Vereinsregisterakte: Gruppo Culturale Italo-Tedesco
Sulle Generatrici del Gruppo Simmetrico.